home / stock / cmpi / cmpi quote
Last: | $10.50 |
---|---|
Change Percent: | 0.0% |
Open: | $10.49 |
Close: | $10.50 |
High: | $10.5 |
Low: | $10.48 |
Volume: | 63,651 |
Last Trade Date Time: | 05/30/2022 04:53:53 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.5 | $10.49 | $10.5 | $10.5 | $10.48 | 63,651 | 05-30-2022 |
$10.5 | $10.49 | $10.5 | $10.5 | $10.48 | 59,987 | 05-27-2022 |
$10.48 | $10.5 | $10.48 | $10.5 | $10.48 | 122,579 | 05-26-2022 |
$10.49 | $10.49 | $10.49 | $10.5 | $10.48 | 180,445 | 05-25-2022 |
$10.49 | $10.47 | $10.49 | $10.4933 | $10.47 | 182,015 | 05-24-2022 |
$10.49 | $10.49 | $10.49 | $10.5 | $10.465 | 116,447 | 05-23-2022 |
$10.46 | $10.47 | $10.46 | $10.49 | $10.46 | 67,678 | 05-20-2022 |
$10.47 | $10.43 | $10.47 | $10.48 | $10.43 | 62,768 | 05-19-2022 |
$10.45 | $10.45 | $10.45 | $10.47 | $10.44 | 507,347 | 05-18-2022 |
$10.47 | $10.46 | $10.47 | $10.47 | $10.44 | 209,595 | 05-17-2022 |
$10.46 | $10.45 | $10.46 | $10.46 | $10.44 | 275,322 | 05-16-2022 |
$10.44 | $10.43 | $10.44 | $10.46 | $10.43 | 76,001 | 05-13-2022 |
$10.43 | $10.4 | $10.43 | $10.44 | $10.37 | 703,918 | 05-12-2022 |
$10.37 | $10.39 | $10.37 | $10.45 | $10.34 | 302,321 | 05-11-2022 |
$10.39 | $10.37 | $10.39 | $10.39 | $10.37 | 135,427 | 05-10-2022 |
$10.38 | $10.37 | $10.38 | $10.39 | $10.37 | 120,825 | 05-09-2022 |
$10.38 | $10.37 | $10.38 | $10.38 | $10.36 | 352,697 | 05-06-2022 |
$10.37 | $10.36 | $10.37 | $10.37 | $10.36 | 233,820 | 05-05-2022 |
$10.37 | $10.39 | $10.37 | $10.39 | $10.35 | 322,387 | 05-04-2022 |
$10.39 | $10.39 | $10.39 | $10.39 | $10.37 | 535,652 | 05-03-2022 |
News, Short Squeeze, Breakout and More Instantly...
Checkmate Pharmaceuticals Inc. Company Name:
CMPI Stock Symbol:
NASDAQ Market:
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules • $2.5 million of milestone to be paid to XOMA Corporation under royalty agreement SCHLIEREN (ZURICH), Switzerland, June 02, 2022 (GLOBE NEWSWIRE) -- Kuros Biosciences AG (“Kuros” ...
CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat c...
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today an...